Biography:
Shivani Arivuchelvan is a Biomedical Science student specialising in Neuroscience at the University of Auckland. As a researcher, her peer-reviewed work on Alpha-1 Antitrypsin Deficiency gene therapy reflects a rigorous ability to critically evaluate therapeutic genomics, assess translational viability, and engage with the ethical dimensions of precision medicine. Her research interests are anchored in neurological disease mechanisms, molecular genetics, and gene-based therapeutic strategies. Shivani is committed to translational research that moves fluidly between bench science and clinical application — with a particular focus on how predictive biological systems and data-driven methodologies can advance molecular medicine and accelerate the identification of therapeutic targets, positioning her at the convergence of molecular research and computationally informed medicine.


Title : Mapping the neuroimmune–decoder divide in chronic brain–computer interfaces: A bibliometric analysis of structural inference gaps in biomarker stability